Paradeep Phosphates (PARADEEP) Q4 22/23 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 22/23 earnings summary
2 Nov, 2026Executive summary
FY23 combined the Goa acquisition and 150% capacity expansion to 3 MMTPA with record output and sales; revenue rose sharply, but PBT, PAT and key returns declined.
Production reached 2.032 million tonnes and sales 2.029 million tonnes; capacity utilisation was 84%, with market share near 8%.
Financial highlights
Consolidated revenue from operations rose 69.76% to ₹13,340.72 crore; EBITDA was ₹892.1 crore, up 26% YoY.
Consolidated PBT fell 20.34% to ₹426.17 crore and PAT fell 23.66% to ₹304.19 crore; standalone EPS declined to ₹3.89 from ₹6.91.
Raw-material costs increased 98.99% to ₹10,439.70 crore; finance costs rose to ₹291.24 crore from ₹85.54 crore, while other income included ₹64.08 crore of excess provisions and unclaimed balances written back.
Operating cash flow was negative ₹2,376.67 crore, mainly reflecting a ₹2,423.75 crore increase in trade receivables; cash and cash equivalents ended at ₹43.03 crore.
Outlook and guidance
FY24 margins were expected to improve with lower input costs, higher captive phosphoric acid capacity of 0.5 MMTPA and the fourth evaporator; projects were targeted for Q1 FY24 completion.
Plans include increasing sulphuric acid capacity by 0.5 MMTPA over two years and expanding markets, product offerings and farmer engagement; a 1,500 TPD sulphuric acid plant with 23 MW power capacity was targeted for completion by 2025.
New NPK formulations and nano-fertiliser development were in progress; agri-service digitisation and distribution-channel technology were also strategic priorities.
Latest events from Paradeep Phosphates
- Profit improved as production volumes fell and working-capital needs drove operating cash outflow.PARADEEP
Q4 18/19 - Lower tax lifted FY20 profit despite weaker revenue and production.PARADEEP
Q4 19/20 - Higher volumes lifted FY22 profit as Goa acquisition and capacity expansion set the growth agenda.PARADEEP
Q4 21/22 - Higher earnings and lower finance costs accompanied a proposed US$280 million Goa acquisition.PARADEEP
Q4 20/21 - H1 revenue grew, but weaker profits and volumes left debt reduction reliant on Rabi sales.PARADEEP
Q2 26/27 - Revenue up 36% YoY, EBITDA up 25%, with strong DAP sales and MCFL merger boosting growth.PARADEEP
Q1 26/27 - Strong growth in revenue, profit, and volumes, boosted by MCFL merger and expansion projects.PARADEEP
Q3 25/26 - Q1 FY26 revenue up 58% YoY, EBITDA nearly doubled, and MCFL merger nears completion.PARADEEP
Q1 25/26 - Net profit up 134.7% YoY in H1 FY26, driven by MCFL merger and major capacity expansion.PARADEEP
Q2 25/26